Largest pharmaceuticals by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

AbbVie leads the 35 pharmaceuticals ranked by total debt, at HK$529.6B, ahead of Pfizer (HK$508.4B) and Merck & Co (HK$386.8B). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
35
First
AbbVieHK$529.6B
Median
HK$41.4B
Combined market value
HK$39.89T
Countries
10
Not ranked
26no total debt on file

Market values as of .

Largest pharmaceuticals by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health CareHK$529.6BHK$4THK$2,262.65 1.52% down 26% up United States
2PfizerPFE · Health CareHK$508.4BHK$1.26THK$221.03 1.05% down 14% up United States
3Merck & CoMRK · Health CareHK$386.8BHK$2.7THK$1,096.03 2.57% down 51% up United States
4Johnson & JohnsonJNJ · Health CareHK$376.1BHK$5.2THK$2,160.21 1.21% down 38% up United States
5Bristol-Myers SquibbBMY · Health CareHK$353.9BHK$962.8BHK$471.01 2.15% down 34% up United States
6Eli LillyLLY · Health CareHK$333.5BHK$9.71THK$10,901.26 1.85% down 35% up United States
7Takeda PharmaceuticalTAK · Health CareHK$239.9BHK$535.7BHK$167.67 1.25% down 54% up Japan
8AstraZenecaAZN · Health CareHK$232.4BHK$2.18THK$1,402.74 1.91% down 2% up United Kingdom
9NovartisNVS · Health CareHK$225.4BHK$2.31THK$1,225.22 1.87% down 25% up Switzerland
10SanofiSNY · Health CareHK$162.8BHK$891.6BHK$371.32 0.43% down 4% down France
11Novo NordiskNVO · Health CareHK$152.5BHK$1.37THK$311.49 2.46% down 17% down Denmark
12GSKGSK · Health CareHK$150.5BHK$767.2BHK$382.74 0.93% down 6% up United Kingdom
13ViatrisVTRS · Health CareHK$113.1BHK$185.7BHK$161.98 0.95% up 96% up United States
14Abbott LaboratoriesABT · Health CareHK$101.4BHK$1.42THK$818.36 0.39% down 17% down United States
15ZoetisZTS · Health CareHK$70.9BHK$267BHK$657.20 0.34% up 29% down United States
16Royalty PharmaRPRX · Health CareHK$70.2BHK$308.8BHK$536.98 0.35% down 78% up United States
17Jazz PharmaceuticalsJAZZ · Health CareHK$42BHK$122.6BHK$1,910.74 1.17% up 37% up Ireland
18GenmabGMAB · Health CareHK$41.4BHK$248.4BHK$402.82 1.19% down 70% up Denmark
19Elanco Animal HealthELAN · Health CareHK$31.5BHK$103.4BHK$206.79 1.95% up 20% up United States
20Amneal PharmaceuticalsAMRX · Health CareHK$20.2BHK$58.9BHK$169.09 2.04% up 83% up United States
21BridgeBio PharmaBBIO · Health CareHK$15.7BHK$118.6BHK$608.71 1.02% up 17% up United States
22Regeneron PharmaceuticalsREGN · Health CareHK$15.6BHK$774.6BHK$7,487.93 0.36% down 36% up United States
23Ionis PharmaceuticalsIONS · Health CareHK$14.2BHK$35.7BHK$214.51 1.41% up 64% down United States
24BeOne MedicinesONC · Health CareHK$8.1BHK$361.9BHK$3,168.21 2.29% down 17% up Switzerland
25Ascendis PharmaASND · Health CareHK$6.3BHK$138.8BHK$2,116.49 0.53% down 28% up Denmark
26InsmedINSM · Health CareHK$4.3BHK$206.6BHK$941.58 1.52% down 40% down United States
27Madrigal PharmaceuticalsMDGL · Health CareHK$2.7BHK$74.8BHK$3,221.06 2.72% down 24% down United States
28Legend BiotechLEGN · Health CareHK$2.5BHK$24.8BHK$127.81 1.12% up 42% down United States
29CytokineticsCYTK · Health CareHK$2.3BHK$55.9BHK$401.57 0.91% down 20% down United States
30TG TherapeuticsTGTX · Health CareHK$1.9BHK$76.6BHK$506.47 2.93% up 107% up United States
31Cogent BiosciencesCOGT · Health CareHK$1.7BHK$38.7BHK$222.64 1.89% up 20% down United States
32Dr. Reddy's LaboratoriesRDY · Health CareHK$1.5BHK$98BHK$117.50 1.25% up 5% up India
33Axsome TherapeuticsAXSM · Health CareHK$1.5BHK$55.1BHK$1,047.07 1.84% down 7% down United States
34Rhythm PharmaceuticalsRYTM · Health CareHK$848.8MHK$63.5BHK$915.65 0.08% up 13% up United States
35Definium TherapeuticsDFTX · Health CareHK$318.4MHK$30.6BHK$223.38 3.10% down 169% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 7.8462 HKD). 26 companies have no total debt on file and are not ranked here.

Questions and answers

Which pharmaceuticals rank first by total debt?

AbbVie (HK$529.6B), Pfizer (HK$508.4B) and Merck & Co (HK$386.8B) are the top three of the 35 pharmaceuticals ranked by total debt as of 18 Nov 2026, 16:15 UTC.

How many pharmaceuticals are in this ranking?

35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.

What are these pharmaceuticals worth together?

The 35 pharmaceuticals ranked by total debt have a combined market value of HK$39.89T as of 18 Nov 2026, 16:15 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest pharmaceuticals by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.